1. Yilmaz, Ö., B. Bayer, H. Bekçi, A.I. Uba, A. Cumaoğlu, K. Yelekci and S.G. Küçükgüzel, 2019. Synthesis, anticancer activity on prostate cancer cell lines and molecular modeling studies of flurbiprofen-thioether derivatives as potential target of MetAP (type II). Med. Chem., (In Press). 10.2174/1573406415666190613162322.
   CrossRef  |  PubMed  |  Direct Link  |  
2. Usman, S.S., M. Dahiru, B. Abdullahi, S.B. Abdullahi, U.M. Maigari and A.I. Uba, 2019. Status of malondialdehyde, catalase and superoxide dismutase levels/activities in schoolchildren with iron deficiency and iron-deficiency anemia of Kashere and its environs in Gombe State, Nigeria. Heliyon, Vol. 5, No. 8. 10.1016/j.heliyon.2019.e02214.
   CrossRef  |  Direct Link  |  
3. Uba, A.I., J. Weako, O. Keskin, A. Gürsoy and K. Yelekçi, 2019. Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation. J. Biomol. Struct. Dynam., (In Press). 10.1080/07391102.2019.1615989.
   CrossRef  |  PubMed  |  Direct Link  |  
4. Uba, A.I. and K. Yelekçi, 2019. Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. J. Biomol. Struct. Dynam., 37: 3627-3636.
   CrossRef  |  PubMed  |  Direct Link  |  
5. Samorlu, A.S., K. Yelekçi and A.I. Uba, 2019. The design of potent HIV-1 integrase inhibitors by a combined approach of structure-based virtual screening and molecular dynamics simulation. J. Biomol. Struct. Dynam., 37: 4644-4650.
   CrossRef  |  PubMed  |  Direct Link  |  
6. Han, M.İ., H. Bekçi, A.I. Uba, Y. Yıldırım and E. Karasulu et al., 2019. Synthesis, molecular modeling, in vivo study and anticancer activity of 1, 2, 4‐triazole containing hydrazide-hydrazones derived from (S)‐naproxen. Arch. Pharm. Chem. Life Sci. Life, Vol. 352, No. 6. 10.1002/ardp.201800365.
   CrossRef  |  PubMed  |  Direct Link  |  
7. Uba, A.I. and K. Yelekçi, 2018. Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6. Comput. Biol. Chem., 77: 318-330.
   CrossRef  |  PubMed  |  Direct Link  |  
8. Uba, A.I. and K. Yelekçi, 2018. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: A combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay. J. Biomol. Struct. Dynam., 36: 3231-3245.
   CrossRef  |  PubMed  |  Direct Link  |  
9. Uba, A.I. and K. Yelekçi, 2018. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies. Comput. Biol. Chem., 75: 131-142.
   CrossRef  |  PubMed  |  Direct Link  |  
10. Uba, A.I., H.O. Tabakoglu, U.A. Abdullahi and M.M. Sani, 2017. Closure of skin incision by dual wavelength (980 and 1064 nm) laser application. J. Cosmetic Laser Ther., 19: 109-113.
    CrossRef  |  PubMed  |  Direct Link  |  
11. Uba, A.I. and K. Yelekci, 2017. Exploration of the binding pocket of histone deacetylases: The design of potent and isoform-selective inhibitors. Turk. J. Biol., 41: 901-918.
    CrossRef  |  PubMed  |  Direct Link  |  
12. Tabakoglu, H.O., M.M. Sani, A.I. Uba and U.A. Abdullahi, 2016. Assessment of circular wound healing in rats after exposure to 808‐nm laser pulses during specific healing phases. Lasers Surg. Med., 48: 409-415.
    CrossRef  |  PubMed  |  Direct Link  |  
13. Abdulazeez, M., H. Aminu, S. Ndanusa and A. Uba, 2016. Isolation and characterization of a new angiotensin-converting enzyme inhibitory peptide from Heterobronchus bidorsalis. J. Biol. Active Prod. Nature, 6: 237-249.
    CrossRef  |  Direct Link  |